But I trusted her. And because of that trust, I gave it a try.
I set the machine to play a 7 Hz wave during my sleep routine, tucked it beneath my pillow, and forgot about it—not out of skepticism, but out of routine. Weeks passed. Then months. And somewhere in that quiet span, I noticed something unexpected: my insomnia, a stubborn companion I had learned to tolerate, had softened. I was falling asleep faster. Staying asleep longer. Waking less often in the gray hours before dawn, my mind already racing.
Do I know, with certainty, that the machine caused this? I do not. As a mental health provider, I am acutely aware that this device has little proven effectiveness on paper. The rational part of me knows that the sleep improvements could be attributed to any number of variables: seasonal changes, reduced stress, natural fluctuation, or the simple fact that I expected to sleep better.
And yet, I am sleeping better. The improvement is real.
This is the paradox of the placebo effect: an inert treatment, given with honest intention, produces measurable, tangible change. The improvement does not require deception. It does not require miracle technology. It requires only a mind capable of believing—and a body capable of listening.
---
Part I: What the Placebo Effect Actually Is (And What It Is Not)
Let us clear the air immediately. The placebo effect is not "fake improvement." It is not evidence that symptoms were imaginary. It is not a sign of weakness, gullibility, or hysteria.
In short, placebo effects are a product of the mind biologically manifesting changes in the body. When a person experiences improved symptoms from a placebo treatment, these benefits are just as real, physical and substantial as if the improvements resulted from a conventional treatment.
Placebo effects arise from the brain's remarkable ability to make predictions about the future and to induce neurotransmitter, hormone, and immune system changes that mimic the effects of actual medicines. This is not magic. It is neurobiology.
The placebo effect has been documented across an extraordinary range of conditions: pain, Parkinson's disease, depression, anxiety, and addiction. Psychological mechanisms—particularly the power of patient expectations—play a central role, with neurobiological evidence supporting the activation of dopamine, endogenous opioids, and endocannabinoids in response to placebo interventions.
In Parkinson's disease, researchers have observed that some patients who received a placebo displayed brain changes on PET scans identical to those produced by levodopa, the gold-standard medication that boosts brain levels of dopamine. The lead author of that 2001 Science study noted that a substantial amount of dopamine was being released—potentially a tenfold increase, equivalent to what you would see after giving a healthy person amphetamines.
This is not a small effect. This is the brain turning on its own pharmacy.
---
Part II: The Honest Placebo—When You Know It's Fake and It Still Works
Here is where the story becomes even more intriguing—and where my own experience with the Schumann machine finds its most resonant echo.
For decades, the medical establishment assumed that placebos worked only through deception. The logic seemed unassailable: if a patient knew they were taking a sugar pill, why would they improve? The expectation of benefit, the cornerstone of placebo theory, would be absent.
The research now tells a different story.
A growing body of evidence demonstrates that open-label placebos—placebos administered with full honesty, where the patient knows the pill contains no active ingredient—can produce genuine therapeutic effects. The data suggests that honesty does not nullify the placebo effect, which opens the door to safe and ethically acceptable therapeutic approaches.
Open-label placebos have shown efficacy across a range of conditions, including irritable bowel syndrome, chronic back pain, migraine, and cancer-related fatigue. In one study of migraine patients, those receiving usual care plus an openly labeled placebo pill reported marked improvements in how migraine attacks affected their daily lives, even though headache frequency remained unchanged. The lead investigator noted that "taking a pill that is openly described as inert can still elicit beneficial responses and strengthen patients' engagement with their condition".
Even more striking: a 2024 study from Michigan State University found that nondeceptive placebos—given to participants who knew exactly what they were—reduced stress, anxiety, and depression in just two weeks. Participants in the nondeceptive placebo group showed a significant decrease in all three measures compared to a no-treatment control group. The researchers concluded that this minimal-burden intervention could be an attractive option for those with significant mental health challenges.
To be clear: these participants knew they were taking placebos. They knew the pills contained no active medication. And they still improved.
This is the scientific foundation beneath my own experience. I do not know if the Schumann resonance machine is "actually working." But I know I am sleeping better. And the research suggests that the belief—the ritual, the expectation, the trust in my colleague—may be sufficient explanation.
---
Part III: The Sleep Connection—Placebos and Insomnia
Insomnia has been a recurring visitor in my life. The racing thoughts, the hypervigilance, the body that refuses to power down even when the mind is exhausted. It is a familiar burden for many who navigate the world with complex trauma or chronic anxiety.
My experience with the Schumann machine aligns with a robust body of placebo research specifically focused on sleep. A systematic review and meta-analysis examining placebo versus no treatment for insomnia symptoms found a reliable placebo effect across multiple measures. Placebo treatment led to improved perceived sleep onset latency (how long it takes to fall asleep), total sleep time, and global sleep quality when compared with no treatment at all. The effect sizes were clinically meaningful, particularly for overall sleep quality.
Another meta-analysis, published in Behavioral Sleep Medicine, challenged the common assumption that placebo responses affect only subjective measures while objective measurements remain unchanged. The analysis found that placebos produced comparable effects on both objective and subjective measures of sleep continuity. In other words, people were not just feeling like they slept better—their actual sleep physiology was changing.
This matters. It suggests that the placebo effect for insomnia is not merely a matter of perception or reporting bias. It reflects genuine, measurable changes in sleep architecture.
For someone like me, waking up less often, feeling more rested, experiencing fewer hours of middle-of-the-night wakefulness—these are not trivial improvements. They are the difference between a regulated nervous system and a dysregulated one. They are the foundation upon which everything else—mood, focus, emotional resilience—is built.
---
Part IV: Placebo and Mental Health—The Numbers Are Stunning
If sleep is one arena where the placebo effect shines, mental health is another.
A 2024 meta-analysis published in JAMA Psychiatry assessed placebo response across nine psychiatric disorders, combining data from 90 high-quality clinical trials and nearly 10,000 participants. The results were remarkable: placebo group participants showed strong symptom improvements across all nine disorders. The greatest placebo response was seen for major depression (effect size 1.40) and generalized anxiety (effect size 1.23)—both considered "very large" effects in clinical research.
The researchers defined a genuine placebo effect as encompassing improvements induced by suggestion, hope for effective treatment, and conditioning effects through the administration of medications. In psychiatric illness, factors such as the episodic course of many disorders and the attentive and compassionate care that clinical trial participants often receive also influence the placebo response.
What this means, practically, is that a significant portion of the improvement seen in antidepressant and anti-anxiety medication trials can be attributed not to the drug's specific biochemical action, but to the broader context of care: the expectation of improvement, the therapeutic relationship, the ritual of taking a pill.
The authors concluded: "A better understanding of placebo responses may improve treatments, especially in psychiatric disorders where confidence, conditioning, and belief play a significant role".
---
Part V: The Neuroplasticity Placebo—How Belief Reshapes the Brain
Perhaps the most exciting recent development in placebo research is the Neuroplasticity Placebo Theory. Developed in a 2024 paper, this theory posits that neuroplasticity in fronto-limbic areas—the brain regions involved in emotion regulation, memory, and decision-making—is the unifying factor in placebo effects.
Depression has the highest placebo response of any medical condition, making it an ideal model for understanding how placebos work. Recent developments in the understanding of depression's pathophysiology suggest that fronto-limbic areas are sensitized in depression, which is associated with a particularly strong placebo phenomenon.
If placebo stimulates neuroplasticity in fronto-limbic areas, then the placebo effect is not merely a statistical artifact or a psychological curiosity. It is a biological intervention—one that harnesses the brain's inherent capacity for change and healing.
The authors propose that the terms "placebo effect" and "placebo response" should be replaced by the single term "placebo treatment" —a shift in language that reflects a fundamental shift in understanding. The placebo is not inert. It is a catalyst. It activates the body's latent healing systems, engaging neurobiological pathways that produce real, measurable changes in health.
This is the framework through which I now understand my Schumann machine. Whether the 7 Hz wave is doing anything physically is almost beside the point. What matters is that the context—my trust in my colleague, my willingness to try, my expectation of benefit, the ritual of placing the device under my pillow each night—has activated my brain's capacity for self-directed healing.
The improvement is real. The mechanism is me.
---
Part VI: The Science of Ritual—Why the Context Matters More Than the Content
This brings us to a crucial insight: the placebo effect is not primarily about the "pill." It is about the ritual.
Research on open-label placebos has shown that the act of taking a pill—the sensory-motor engagement of swallowing, the routine of medication at a specific time, the conscious decision to engage in a healing practice—may be a pivotal component of the effect. It is not enough to have a conscious expectation that a treatment will work. There is evidence that unconscious processes play a central role in the open-label placebo effect, suggesting that belief, ritual, and embodied practice combine in ways that cognitive expectation alone cannot explain.
This is where my Schumann machine becomes more than a gadget. It is a ritual object. Each night, I plug it in, set the frequency, place it under my pillow. These actions are small, but they are intentional. They signal to my brain: "We are doing something for our sleep. We are taking care of ourselves. This matters."
The neuroscientific literature supports this interpretation. Placebo responses are mediated by "top-down" processes dependent on frontal cortical areas that generate and maintain cognitive expectancies. Neuroimaging studies reveal that placebo treatments activate brain regions involved in pain modulation, such as the prefrontal cortex and anterior cingulate cortex, while engaging endogenous pathways that underpin therapeutic outcomes.
The context of care—the expectation, the relationship, the ritual—is not an add-on to treatment. It is treatment.
---
Part VII: A Personal Reflection—Healing Without Certainty
I am a mental health provider. I have spent years learning to distinguish between evidence-based interventions and those that rest on shaky foundations. By every objective measure, the Schumann resonance machine belongs in the latter category. The research is not there. The mechanisms are speculative. If a client asked me whether they should buy one, I would likely advise them to save their money and invest in proven sleep hygiene practices instead.
And yet, I continue to use the machine. And I continue to sleep better.
This is not hypocrisy. It is a recognition that healing is not a purely rational enterprise. The mind does not operate on PubMed abstracts alone. We are creatures of belief, of ritual, of expectation. These are not weaknesses to be overcome. They are resources to be harnessed.
The placebo effect is not a trick we play on ourselves. It is a fundamental feature of human biology. It is the mechanism through which hope becomes healing, through which expectation becomes physiology, through which the intangible becomes tangible.
I do not need to know why the machine is working. I only need to know that it is—and to honor that reality without demanding that it fit neatly into my clinical frameworks.
---
Part VIII: Practical Implications—How to Intentionally Harness the Placebo Effect
If you have read this far, you may be wondering: how can I use this in my own life? The answer is simpler than you might think.
Embrace Ritual. The placebo effect thrives on intentional, repeated action. A morning cup of tea prepared with care. A nightly skincare routine. A specific stretch sequence before bed. These rituals are not empty—they are signals to your nervous system that you are safe, that you are cared for, that healing is underway.
Cultivate Positive Expectation. The research is clear that expectation is a primary mechanism of placebo effects. This does not mean deluding yourself. It means consciously orienting toward the possibility of improvement. It means saying to yourself, "I am doing something good for myself. I expect to feel better." This is not magical thinking. It is neurobiological priming.
Trust Someone. Much of the placebo effect is mediated through relationship. The colleague who gave me the machine, the therapist who recommends a practice, the friend who swears by a particular intervention—trust in another person activates social engagement systems that reduce threat perception and open the door to healing.
Pay Attention to Context. The environment matters. Soft lighting, comfortable seating, absence of interruption—these are not luxuries. They are placebo amplifiers. They tell your brain that this moment matters, that you are worth caring for, that improvement is possible.
Do Not Fear the "Placebo Label." Many people resist the idea that their improvement could be "just placebo." This is a misunderstanding. Placebo effects are real effects. If something helps you—even if the mechanism is "all in your head"—that help is valid, legitimate, and worth keeping.
---
Conclusion: The Permission to Believe
When I placed that Schumann resonance machine under my pillow on the first night, I was not certain it would help. I am still not certain. But the evidence of my own experience—the quieter nights, the gentler mornings, the reduced frequency of waking at 3 AM with my heart already racing—is not nothing. It is data. It is my data.
As a mental health provider, I have spent years helping clients navigate the gap between what the research says and what their bodies tell them. The placebo effect sits squarely in that gap. It is the bridge between evidence and experience, between the cold numbers of clinical trials and the warm reality of a person sleeping better.
The Schumann machine may not be "scientific." But my insomnia reduction is. And that reduction has been achieved through a combination of factors that includes, almost certainly, a substantial placebo component.
This is not a confession of self-deception. It is an embrace of a fundamental truth: the mind is not separate from the body. Belief is not separate from biology. Healing is not always rational, but it is always real.
So I will continue to place the machine under my pillow. And I will continue to sleep. And I will continue to hold both truths at once: the knowing that the science is thin, and the knowing that the improvement is thick.
That is not contradiction. That is the placebo effect. And it is one of the most remarkable medicines we possess.
Find me at:
YouTube : Gaming for Mental Health
---
Sources
1. Psychology Today (2022). How Placebo Treatments Work. Explains that placebo effects arise from the brain's ability to make predictions and induce neurotransmitter, hormone, and immune changes. Notes that placebo effects are "a product of the mind biologically manifesting changes in the body" and are "just as real, physical and substantial as if the improvements resulted from a conventional treatment."
2. PMC / Medicines (2025). Justice for Placebo: Placebo Effect in Clinical Trials and Everyday Practice. Reviews evidence that placebo responses can significantly improve symptoms in pain, Parkinson's disease, depression, anxiety, and addiction. Notes that psychological mechanisms (patient expectations) play a central role, supported by neurobiological evidence of dopamine, endogenous opioid, and endocannabinoid activation.
3. Neurology Today / AAN (2008). Why Research Supports the Practice (of a Placebo Effect). Reports on PET and fMRI evidence that placebo response in Parkinson's disease produces brain changes identical to levodopa, with dopamine release equivalent to amphetamine effects in healthy persons. Notes that expectation of benefit is a key mechanism driven by dorsolateral prefrontal, orbitofrontal, and anterior cingulate cortices.
4. Nature Communications / PMC (2020). Placebos without deception reduce self-report and neural measures of emotional distress. Demonstrates that non-deceptive placebos reduce both self-report and neural measures (late positive potential) of emotional distress, confirming that effects are not merely response bias.
5. Bial Foundation / Beyond the Brain (2026). Can open-label placebos work even when we know they are "inert"? Summarizes research showing that honesty does not nullify the placebo effect, that unconscious processes play a central role, and that belief in placebos is associated with greater reduction in emotional stress.
6. Medscape (2025). 'Honest' Placebos Tied to Better Functioning for Migraineurs. Reports on open-label placebo study in migraine patients showing reduced pain-related disability and improved well-being despite unchanged headache frequency. Lead author notes that open-label placebos could serve as safe adjuncts to preventive care.
7. Michigan State University / EurekAlert (2024). MSU study finds placebos reduce stress, anxiety, depression — even when people know they are placebos. RCT of nondeceptive placebos administered remotely showed significant decreases in stress, anxiety, and depression in just two weeks. Co-author notes that "an intervention that takes minimal effort can still lead to significant benefits."
8. Infona (systematic review). A systematic review and meta-analysis of placebo versus no treatment for insomnia symptoms. Meta-analysis of 13 studies (n=566) found reliable placebo effects for perceived sleep onset latency (g=0.272), total sleep time (g=0.322), and global sleep quality (g=0.581) compared with no treatment.
9. PubMed / Behavioral Sleep Medicine (2022). Do Placebos Primarily Affect Subjective as Opposed to Objective Measures? A Meta-Analysis of Placebo Responses in Insomnia RCTs. Meta-analysis (879 subjects with PSG data, 1,209 with diary data) found placebos produce comparable effects on objective and subjective sleep continuity measures, suggesting objective measures do not protect against placebo responses.
10. PMC / Frontiers in Psychiatry (2024). Placebo stimulates neuroplasticity in depression: implications for clinical practice and research. Develops Neuroplasticity Placebo Theory, positing that neuroplasticity in fronto-limbic areas is the unifying factor in placebo effects. Argues that if placebo stimulates neuroplasticity, it should be considered a "placebo treatment" rather than an inert comparator.
11. Psychiatric Times (2025). Placebo Response Rates Vary Across Psychiatric Disorders. Reports that placebo effects show significant symptom improvement across psychiatric disorders, with largest effects in MDD and GAD. Notes factors including therapeutic environment and patient expectations.
12. Psychiatric News / APA (2024). Placebo Response Strongest in Depression Trials, but Robust Across Multiple Psychiatric Disorders. Meta-analysis of 90 RCTs (nearly 10,000 participants) found placebo effect sizes of 1.40 for depression and 1.23 for GAD, considered "very large" effects. Authors note that placebo effects include "suggestion, hope for effective treatment, and conditioning effects."
13. Karger (2024). Nocebo and Placebo Effects and Their Implications in Psychotherapy. Reviews that the major mechanism involved in placebo and nocebo effects is patients' treatment expectations, and that placebo research offers strategies to improve psychotherapy by increasing efficacy and reducing side effects.
14. Neuroimaging review / PubMed (2008). Imaging the placebo response: a neurofunctional review. Notes that placebo responses are mediated by "top-down" processes dependent on frontal cortical areas that generate and maintain cognitive expectancies.
15. PMC (2022). Placebo and nocebo effects: from observation to harnessing and clinical application. Reviews advances in employing psychosocial, pharmacological, and neuromodulation approaches to modulate placebo effects. Notes that expectations and learning are two frequently studied behavioral mechanisms.
Comments
Post a Comment